These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21078202)

  • 1. Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum.
    Monatrakul P; Mungthin M; Dondorp AM; Krudsood S; Udomsangpetch R; Wilairatana P; White NJ; Chotivanich K
    Malar J; 2010 Nov; 9():326. PubMed ID: 21078202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.
    Kurth F; Pongratz P; Bélard S; Mordmüller B; Kremsner PG; Ramharter M
    Malar J; 2009 Apr; 8():79. PubMed ID: 19389221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs.
    Fall B; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Wade B; Bercion R; Pradines B
    Malar J; 2011 Oct; 10():310. PubMed ID: 22014157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive effects of the anti-oxidant N-acetylcysteine on the anti-malarial activity of artesunate.
    Arreesrisom P; Dondorp AM; Looareesuwan S; Udomsangpetch R
    Parasitol Int; 2007 Sep; 56(3):221-6. PubMed ID: 17544319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antimalarial drugs on movement of Plasmodium falciparum.
    Wongtanachai J; Silamut K; Day NP; Dondorp A; Chaisri U
    Southeast Asian J Trop Med Public Health; 2012 Jan; 43(1):1-9. PubMed ID: 23082547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of mimicking febrile temperature and drug stress on malarial development.
    Aunpad R; Somsri S; Na-Bangchang K; Udomsangpetch R; Mungthin M; Adisakwattana P; Chaijaroenkul W
    Ann Clin Microbiol Antimicrob; 2009 Jun; 8():19. PubMed ID: 19523215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates.
    Rutvisuttinunt W; Chaorattanakawee S; Tyner SD; Teja-Isavadharm P; Se Y; Yingyuen K; Chaichana P; Bethell D; Walsh DS; Lon C; Fukuda M; Socheat D; Noedl H; Schaecher K; Saunders DL
    Malar J; 2012 Sep; 11():325. PubMed ID: 22974086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
    Muhamad P; Thiengsusuk A; Phompradit P; Na-Bangchang K
    Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.
    Parquet V; Henry M; Wurtz N; Dormoi J; Briolant S; Gil M; Baret E; Amalvict R; Rogier C; Pradines B
    Malar J; 2010 May; 9():139. PubMed ID: 20497586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro.
    Nakornchai S; Konthiang P
    Acta Trop; 2006 Dec; 100(3):185-91. PubMed ID: 17126280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum.
    Chotivanich K; Mungthin M; Ruengweerayuth R; Udomsangpetch R; Dondorp AM; Singhasivanon P; Pukrittayakamee S; White NJ
    Malar J; 2012 May; 11():177. PubMed ID: 22640826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved SYBR Green-1-based fluorescence method for the routine monitoring of Plasmodium falciparum resistance to anti-malarial drugs.
    Dery V; Duah NO; Ayanful-Torgby R; Matrevi SA; Anto F; Quashie NB
    Malar J; 2015 Dec; 14():481. PubMed ID: 26625907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003.
    Suwandittakul N; Chaijaroenkul W; Harnyuttanakorn P; Mungthin M; Na Bangchang K
    Korean J Parasitol; 2009 Jun; 47(2):139-44. PubMed ID: 19488420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs.
    Pascual A; Basco LK; Baret E; Amalvict R; Travers D; Rogier C; Pradines B
    Malar J; 2011 Jan; 10():8. PubMed ID: 21235757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.
    Thanh NV; Toan TQ; Cowman AF; Casey GJ; Phuc BQ; Tien NT; Hung NM; Biggs BA
    Malar J; 2010 Jun; 9():181. PubMed ID: 20573274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.
    Pascual A; Parola P; Benoit-Vical F; Simon F; Malvy D; Picot S; Delaunay P; Basset D; Maubon D; Faugère B; Ménard G; Bourgeois N; Oeuvray C; Didillon E; Rogier C; Pradines B
    Malar J; 2012 Feb; 11():45. PubMed ID: 22333675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory detection of artemisinin-resistant Plasmodium falciparum.
    Chotivanich K; Tripura R; Das D; Yi P; Day NP; Pukrittayakamee S; Chuor CM; Socheat D; Dondorp AM; White NJ
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3157-61. PubMed ID: 24663013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
    Lim P; Wongsrichanalai C; Chim P; Khim N; Kim S; Chy S; Sem R; Nhem S; Yi P; Duong S; Bouth DM; Genton B; Beck HP; Gobert JG; Rogers WO; Coppee JY; Fandeur T; Mercereau-Puijalon O; Ringwald P; Le Bras J; Ariey F
    Antimicrob Agents Chemother; 2010 May; 54(5):2135-42. PubMed ID: 20194689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.